News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
832,545 Results
Type
Article (85697)
Company Profile (650)
Press Release (746198)
Section
Business (232033)
Career Advice (4118)
Deals (39677)
Drug Delivery (120)
Drug Development (90663)
Employer Resources (194)
FDA (17941)
Job Trends (17283)
News (395214)
Policy (39634)
Tag
Academia (2973)
Alliances (56543)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (107)
Approvals (17901)
Artificial intelligence (160)
Bankruptcy (396)
Best Places to Work (12498)
Biotechnology (447)
Breast cancer (171)
Cancer (1422)
Career advice (3520)
CAR-T (120)
Cell therapy (341)
Clinical research (71971)
Collaboration (561)
Compensation (264)
COVID-19 (2801)
C-suite (127)
Data (1294)
Diabetes (147)
Diagnostics (6637)
Earnings (94305)
Employer resources (166)
Events (126943)
Executive appointments (433)
FDA (18573)
Funding (465)
Gene therapy (236)
GLP-1 (682)
Government (5054)
Healthcare (20696)
Infectious disease (2883)
Inflammatory bowel disease (128)
Interviews (808)
IPO (17627)
Job creations (5180)
Job search strategy (2857)
Layoffs (498)
Legal (10052)
Lung cancer (212)
Manufacturing (216)
Medical device (14286)
Medtech (14291)
Mergers & acquisitions (22136)
Metabolic disorders (466)
Neuroscience (1734)
NextGen: Class of 2025 (7657)
Non-profit (5053)
Northern California (1688)
Obesity (263)
Opinion (254)
Patents (121)
People (64375)
Pharmaceutical (132)
Phase I (22218)
Phase II (31277)
Phase III (23528)
Pipeline (572)
Postmarket research (3543)
Preclinical (9981)
Radiopharmaceuticals (245)
Rare diseases (280)
Real estate (7371)
Regulatory (26076)
Research institute (2642)
Resumes & cover letters (649)
Southern California (1463)
Startups (4276)
United States (15255)
Vaccines (645)
Weight loss (205)
Date
Today (114)
Last 7 days (479)
Last 30 days (1899)
Last 365 days (33463)
2025 (1842)
2024 (34372)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57670)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1261)
Arizona (226)
Asia (49483)
Australia (8732)
California (3872)
Canada (1307)
China (349)
Colorado (141)
Connecticut (167)
Europe (113196)
Florida (468)
Georgia (113)
Illinois (383)
Indiana (224)
Maryland (691)
Massachusetts (3167)
Michigan (165)
Minnesota (274)
New Jersey (1094)
New York (1085)
North Carolina (854)
Northern California (1688)
Ohio (131)
Pennsylvania (860)
South America (1646)
Southern California (1463)
Texas (530)
Washington State (415)
832,545 Results for "federation bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amphix Bio lands federal and state grants to manufacture regenerative therapies
November 1, 2024
·
3 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Patents
Patent Thickets in Federal Government’s Crosshairs as Election 2024 Looms
Congress, the Federal Trade Commission and the U.S. Patent and Trademark Office are all targeting Big Pharma’s practice of filing multiple, overlapping patents that stifle generic and biosimilar competition.
August 28, 2024
·
7 min read
·
Greg Slabodkin
Press Releases
Vivacelle Bio to Participate in BIO Partnering @ JPM Week 2025
January 10, 2025
·
2 min read
Deals
Kanvas Biosciences Acquires Federation Bio Assets to Scale the Discovery, Development and Manufacturing of Microbiome-Based Therapeutics
Kanvas Biosciences today announced it acquired two active therapeutics programs, a microbial library, and intellectual property from Federation Bio, a manufacturer of live biotherapeutics products (LBPs).
October 11, 2023
·
5 min read
Press Releases
CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities
January 21, 2025
·
3 min read
Layoffs
Bluebird Bio to Lay Off 25% of Workforce
About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it will lay off about 25% of its employees, over half of whom work in R&D.
September 24, 2024
·
1 min read
·
Angela Gabriel
Press Releases
89bio Provides Business Update and Outlook for 2025
January 14, 2025
·
5 min read
Press Releases
Mercury Bio Appoints Biotech Innovator Alex Koglin, Ph.D. to Board of Directors
With the addition of NTx’s co-founder and former President to the board Mercury Bio significantly enhances its strategic reach in the biotech sector
October 1, 2024
·
2 min read
Legal
Regeneron Sues Sandoz in Federal Court to Block Eylea Biosimilar
In its legal complaint, filed in the District Court for New Jersey, Regeneron alleges that Sandoz failed to provide it with relevant information required under the Biologics Price Competition and Innovation Act.
August 29, 2024
·
2 min read
·
Tristan Manalac
1 of 83,255
Next
